Search - tctmd.com

Displaying 941 - 960 of 1032

Sort: Relevancy | Date

Presentation TCT 2013

TCT-39. 12-Month Angiographic and Clinical Results of the ReZolve® Sirolimus-Eluting Bioresorbable Coronary Scaffold: The RESTORE trial

Presenter: Ricardo Costa

October 29, 2013

Presentation TCT 2013

TCT-37. Prospective, Multi-Center Evaluation of the DESolve Nx Novolimus-Eluting Bioresorbable Coronary Scaffold: First Report of One Year Clinical and Imaging Outcomes

Presenter: Martin Leon

October 29, 2013

Presentation TCT 2013

TCT-36. One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSO...

Presenter: Takashi Muramatsu

October 29, 2013

Presentation TCT 2013

TCT-34. The appearance of jailed side branches post-procedure, at 6, 12, 24 and 36 months following implantation of bioresorbable vascular devices – Insights from the ABSORB...

Presenter: Yoshinobu Onuma

October 29, 2013

Presentation TCT 2013

TCT-33. Bioresorbable Vascular Scaffold Use in Coronary Bifurcation Lesions

Presenter: Toru Naganuma

October 29, 2013

Presentation TCT 2013

TCT-32. First Report of the Four Year Clinical Results of The ABSORB Trial Evaluating the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Patients...

Presenter: Bernard Chevalier

October 29, 2013

Presentation TCT 2013

Long-term Safety of Everolimus-Eluting Bioresorbable Vascular Scaffold versus Cobalt-Chromium XIENCE V Stent in a Porcine Coronary Artery Model

Presenter: Fumiyuki Otsuka

October 29, 2013

News Conference News TCT 2013

State of the Stent: PCI Future Intact Despite Costs, Sociopolitical Factors

October 29, 2013

Presentation TCT 2013

Do I Really Need Bioresorbable Scaffolds in Germany?

Presenter: Bernhard Witzenbichler

October 28, 2013

Presentation TCT 2013

Bioresorbable Vascular Scaffolds

Presenter: Robert-Jan van Geuns

October 28, 2013

Presentation TCT 2013

Bioresorbable Scaffolds in Bifurcation Applications: Technique Considerations and outcomes

Presenter: Vladimir Dzavik

October 28, 2013

Presentation TCT 2013

Practical Suggestions for Imaging Modalities to Guide Bioresorbable Scaffold Deployment and Follow-Up Assessment

Presenter: Robert-Jan van Geuns

October 28, 2013

Presentation TCT 2013

Do I Really Need Bioresorbable Scaffolds in the United States?

Presenter: Gregg Stone

October 28, 2013

Presentation TCT 2013

Case 2: A Patient Who Might Benefit More from a Bioresorbable Scaffold Than a Metallic DES

Presenter: Sigmund Silber

October 28, 2013

Presentation TCT 2013

Bioresorbable Scaffolds from Metal and Polymers: Landscape and Clinical Experiences

Presenter: Jochen W?hrle

October 28, 2013

News Industry News

CRF and UCR Announce Initiation of PROSPECT II Clinical Trial

October 28, 2013

News Conference News TCT 2013

Bioresorbable Scaffold Stands Ground Next to Current DES

October 28, 2013

News Industry News

Arterial Remodeling Technologies (‘ART’) reports 30-day results for the ‘ARTDIVA’ clinical trial of its next-generation bioresorbable stent at ‘TCT 2013’ annual scientific meeting

October 28, 2013

News Conference News TCT 2013

ABSORB III and IV Trials Aim to Prove Superiority of BVS

October 28, 2013

Presentation TCT 2013

The Case for a Bioresorbable Polymeric Platform!

Presenter: Syed Hossainy

October 27, 2013

Advertisement

TCT-39. 12-Month Angiographic and Clinical Results of the ReZolve® Sirolimus-Eluting Bioresorbable Coronary Scaffold: The RESTORE trial

TCT-37. Prospective, Multi-Center Evaluation of the DESolve Nx Novolimus-Eluting Bioresorbable Coronary Scaffold: First Report of One Year Clinical and Imaging Outcomes

TCT-36. One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSO...

TCT-34. The appearance of jailed side branches post-procedure, at 6, 12, 24 and 36 months following implantation of bioresorbable vascular devices – Insights from the ABSORB...

TCT-33. Bioresorbable Vascular Scaffold Use in Coronary Bifurcation Lesions

TCT-32. First Report of the Four Year Clinical Results of The ABSORB Trial Evaluating the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Patients...

Long-term Safety of Everolimus-Eluting Bioresorbable Vascular Scaffold versus Cobalt-Chromium XIENCE V Stent in a Porcine Coronary Artery Model

State of the Stent: PCI Future Intact Despite Costs, Sociopolitical Factors

Do I Really Need Bioresorbable Scaffolds in Germany?

Bioresorbable Vascular Scaffolds

Bioresorbable Scaffolds in Bifurcation Applications: Technique Considerations and outcomes

Practical Suggestions for Imaging Modalities to Guide Bioresorbable Scaffold Deployment and Follow-Up Assessment

Do I Really Need Bioresorbable Scaffolds in the United States?

Case 2: A Patient Who Might Benefit More from a Bioresorbable Scaffold Than a Metallic DES

Bioresorbable Scaffolds from Metal and Polymers: Landscape and Clinical Experiences

CRF and UCR Announce Initiation of PROSPECT II Clinical Trial

Bioresorbable Scaffold Stands Ground Next to Current DES

Arterial Remodeling Technologies (‘ART’) reports 30-day results for the ‘ARTDIVA’ clinical trial of its next-generation bioresorbable stent at ‘TCT 2013’ annual scientific meeting

ABSORB III and IV Trials Aim to Prove Superiority of BVS

The Case for a Bioresorbable Polymeric Platform!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content